BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial

  • 📰 ABSCBNNews
  • ⏱ Reading Time:
  • 54 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 83%

Philippines Headlines News

Philippines Latest News,Philippines Headlines

BioNTech and Pfizer's COVID19 vaccine shows potential in human trial

FRANKFURT - A COVID-19 vaccine developed by German biotech firm BioNTech and US pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said Wednesday.

BioNTech's shares were up 4.6 percent, after rising as much as 19 percent to reach their highest in more than 3 months. It said the higher of the 2 doses - both administered via 2 injections within 3 weeks of one another - was followed by a short fever in 3 out of 4 participants after the second shot.

He said larger trials were being prepared to show whether this translates into protection against a real infection. Early-stage human trials of vaccines are designed to measure certain antibodies and other immune markers in the blood as an indicator of the body's readiness to fight an infection that then requires further validation.

If it eventually gets marketing approval, the companies are gearing up to make up to 100 million doses by the end of 2020 and another 1.2 billion doses by the end of 2021 at sites in Germany and the United States.The manuscript with the preliminary data from the clinical trials, which were launched in April and May, is under peer review for publication in a scientific journal, BioNTech said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 5. in PH

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

BioNTech, Pfizer report progress in coronavirus vaccine trialKnown as BNT162b1, it produces antibody responses at or above the levels seen in any convalescent serum – blood from people who have recovered – at relatively low doses. You don’t want an exaggerated response
Source: rapplerdotcom - 🏆 4. / 86 Read more »

India's first COVID-19 vaccine candidate approved for human trialsIndia vaccine yes, China vaccine no. Goodluck India!!! Sana all!
Source: ABSCBNNews - 🏆 5. / 83 Read more »

Migo Adecer calls himself lucky to be in Hong Kong during the pandemicMigo Adecer is grateful for how well Hong Kong handled the COVID-19 pandemic. READ HERE:
Source: gmanetwork - 🏆 12. / 63 Read more »

PH COVID-19 cases may hit a staggering 60,000 by end of July—expertsMANILA, Philippines — Despite the government’s claim that the country is “winning” the fight against COVID-19, experts projections showed that coronavirus infections in the Philippines may
Source: cebudailynews - 🏆 8. / 71 Read more »

BioNTech, Pfizer report progress in coronavirus vaccine trialKnown as BNT162b1, it produces antibody responses at or above the levels seen in any convalescent serum – blood from people who have recovered – at relatively low doses. You don’t want an exaggerated response
Source: rapplerdotcom - 🏆 4. / 86 Read more »

Fujifilm ties up with Indian firm on potential COVID-19 drug Avigan
Source: ANCALERTS - 🏆 26. / 50 Read more »